Product Image

Glucosamine + Chondroitin + MSM

Jarrow Formulas
4.7
★ ★ ★ ★ ★
(7010 ratings)
Sodium 120 mg
Potassium 260 mg
Product Image
Score68
Glucosamine, chondroitin, and MSM are fully quantified in a good-value joint formula. Moderate potassium is a secondary benefit, not a reason to use it for heart support.
How scoring works
Quantity:120 Capsule(s) • (30 servings)
Goals:

Score 68

Glucosamine, chondroitin, and MSM are fully quantified in a good-value joint formula. Moderate potassium is a secondary benefit, not a reason to use it for heart support.
How scoring works
$15.40($0.51 per serving)
Amazon
$ 27.47
Vitacost
$ 25.09
Daily Vita
$ 24.99
Vitacost
$ 28.83
iHerb
$ 29.36
Daily Vita
$ 15.40
Report prices

Analysis

The serving combines 1,500 mg of glucosamine sulfate, 1,200 mg of chondroitin sulfate, and 300 mg of MSM. Vitamin C and manganese add supportive nutrients, and all listed active amounts are visible.

Potassium is supplied at 260 mg from glucosamine sulfate potassium chloride, while sodium reaches 120 mg from chondroitin sulfate sodium. The named forms improve label clarity but do not make the joint formula a strong electrolyte or heart product.

The relatively low serving cost can be attractive when all three joint ingredients are wanted. Chondroitin requires caution with anticoagulants, and people who restrict potassium need to include the listed amount in their daily intake.

Who is it for
  • Adults wanting glucosamine, chondroitin, and MSM
  • Value-conscious joint-supplement users
Best for
  • Multi-ingredient joint routines
  • Users who want named mineral sources

Pros

  • Discloses all main active amounts
  • Adds MSM, vitamin C, and manganese
  • Relatively low serving cost

Cons

  • MSM amount is modest
  • Poor alignment with heart-health use
  • Requires four capsules per serving

Warnings

  • Chondroitin may increase bleeding risk with warfarin or other anticoagulants.
  • The 260 mg potassium serving may not suit impaired kidney function or potassium-retaining medicines.

Nutrient quality

57 Moderate impact

Sodium is carried by chondroitin sulfate, which is not a conventional hydration salt. The 120 mg sodium amount is too low for substantial sweat replacement.

.

Ingredient transparency

81 Highest impact

Active amounts are listed clearly. No proprietary blend hides a key dose, but other ingredients and full directions are missing.

.

Customer satisfaction

65 High impact

The supplied average rating is generally strong and the rating volume provides an aggregate signal. No comment-level evidence is provided to assess recurring complaints or confirm how experience matches the intended purpose.

.

Value for money

67 High impact

The broader formula may offer utility, though sodium-specific value is only moderate. The main non-electrolyte actives are purposeful rather than obvious padding.

.
Report analysis

Ingredients

IngredientAmount per serving
Vitamin C (Ascorbic Acid)
60 mg
Manganese (Manganese Citrate)
1 mg
Sodium (Chondroitin Sulfate Sodium)
120 mg
Potassium (Glucosamine Sulfate Potassium Chloride)
260 mg
Glucosamine Sulfate
1500 mg
Chondroitin Sulfate
1200 mg
Methylsulfonylmethane
300 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
D+ Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyA+ Value

The sodium amount is too low for exercise replenishment and comes from chondroitin sulfate sodium rather than a conventional hydration salt. Potassium is clearly measured, but the formula lacks magnesium and buffering support. Its low serving cost reflects a joint formula and does not compensate for limited electrolyte utility.

D+ Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyC+ Value

A moderate potassium contribution accompanies glucosamine, chondroitin, and MSM in this joint-focused formula. Potassium chloride is serviceable for electrolyte intake but is not an alkalizing premium source. The relatively low serving cost improves value when the joint ingredients are also desired.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  2. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  3. Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative.
    Seth A; Mossavar-Rahmani Y; Kamensky V; Silver B; Lakshminarayan K; Prentice R; Van Horn L; Wassertheil-Smoller S · Stroke · 2015
    Cohort study90,137 participantsHeart Health forPotassium
  4. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  5. Associations between sodium, potassium, and blood pressure: results from the Hispanic Community Health Study/Study of Latinos, a prospective cohort study.
    Swift SL; Sotres-Alvarez D; Raij L; Wassertheil-Smoller S; Schneiderman N; Llabre M; Zeki Al Hazzouri A; Rundek T; Van Horn L; Daviglus M; Castaneda S; Youngblood M; Mossavar-Rahmani Y; Elfassy T · The American journal of clinical nutrition · 2024
    Cohort study11,429 participantsHeart Health forPotassium
  6. Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables.
    Toledo CC; Vellosa Schwartzmann P; Miguel Silva L; da Silva Ferreira G; Bianchini Cardoso F; Citelli Ribeiro V; Paim LR; Antunes-Correa LM; Carvalho Sposito A; Matos Souza JR; Modolo R; Nadruz W; Fernandes de Carvalho LS; Coelho-Filho OR · ESC heart failure · 2021
    Cohort study178 participantsHeart Health forPotassium
  7. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
    Núñez J; Bayés-Genís A; Zannad F; Rossignol P; Núñez E; Bodí V; Miñana G; Santas E; Chorro FJ; Mollar A; Carratalá A; Navarro J; Górriz JL; Lupón J; Husser O; Metra M; Sanchis J · Circulation · 2019
    Cohort study2,164 participantsHeart Health forPotassium
  8. Effect of high potassium diet on endothelial function.
    Blanch N; Clifton PM; Petersen KS; Willoughby SR; Keogh JB · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2015
    Randomized trial35 participantsHeart Health forPotassium